doxazosin and c-peptide

doxazosin has been researched along with c-peptide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hakui, N; Kamada, T; Kawamori, R; Sekiya, M; Shiba, Y; Tsujino, T; Yamasaki, Y	1
Allendorf-Ostwald, N; Fliser, D; Hübinger, A; Kohl, B; Nowack, R; Ritz, E	1
Adachi, M; Hirano, T; Kashiwazaki, K; Yoshino, G	1

Trials

1 trial(s) available for doxazosin and c-peptide

Article	Year
Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade. American journal of hypertension, 1993, Volume: 6, Issue:4 Topics: Adrenergic alpha-Antagonists; Adult; Blood Glucose; C-Peptide; Diet, Sodium-Restricted; Doxazosin; Fasting; Female; Humans; Insulin; Lipids; Male	1993

Other Studies

2 other study(ies) available for doxazosin and c-peptide

Article	Year
Selective alpha 1-adrenergic inhibition improves decrease glucose disposal in patients with essential hypertension. Journal of human hypertension, 1994, Volume: 8, Issue:8 Topics: Administration, Oral; Adult; Blood Glucose; Blood Pressure; C-Peptide; Case-Control Studies; Doxazosin; Female; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Secretion; Male	1994
Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients. American journal of hypertension, 2001, Volume: 14, Issue:9 Pt 1 Topics: Aged; Antihypertensive Agents; Apolipoproteins; Blood Glucose; Blood Pressure; C-Peptide; Cholesterol; Diabetes Mellitus, Type 2; Doxazosin; Female; Glycated Hemoglobin; Humans; Hypertension; Insulin Resistance; Lipids; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Prevalence; Triglycerides	2001

Article

Year

Selective alpha 1-adrenergic inhibition improves decrease glucose disposal in patients with essential hypertension.

Journal of human hypertension, 1994, Volume: 8, Issue:8

Topics: Administration, Oral; Adult; Blood Glucose; Blood Pressure; C-Peptide; Case-Control Studies; Doxazosin; Female; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Secretion; Male

1994

Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients.

American journal of hypertension, 2001, Volume: 14, Issue:9 Pt 1

Topics: Aged; Antihypertensive Agents; Apolipoproteins; Blood Glucose; Blood Pressure; C-Peptide; Cholesterol; Diabetes Mellitus, Type 2; Doxazosin; Female; Glycated Hemoglobin; Humans; Hypertension; Insulin Resistance; Lipids; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Prevalence; Triglycerides

2001